These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2681461)

  • 1. A peptidoglycan protein complex purified from M. leprae cell walls contains most or all immunodominant M. leprae T-cell antigens.
    Mutis T; van Schooten WC; de Vries RR
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):788-93. PubMed ID: 2681461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells.
    Janson AA; Klatser PR; van der Zee R; Cornelisse YE; de Vries RR; Thole JE; Ottenhoff TH
    J Immunol; 1991 Nov; 147(10):3530-7. PubMed ID: 1940353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
    J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope on 65-kDa hsp of mycobacteria.
    Haanen JB; Ottenhoff TH; Lai A Fat RF; Soebono H; Spits H; de Vries RR
    J Immunol; 1990 Dec; 145(11):3898-904. PubMed ID: 1701000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Mycobacterium leprae cell wall-associated proteins with the use of T lymphocyte clones.
    Mehra V; Bloom BR; Torigian VK; Mandich D; Reichel M; Young SM; Salgame P; Convit J; Hunter SW; McNeil M
    J Immunol; 1989 Apr; 142(8):2873-8. PubMed ID: 2649562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
    Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR-restricted antigen-induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. leprae.
    Mustafa AS; Qvigstad E
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):1-11. PubMed ID: 2659694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M. leprae recombinant antigens important for T-cell reactivity.
    Mustafa AS
    Indian J Lepr; 1999; 71(1):75-86. PubMed ID: 10439328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
    Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity among human T cell clones recognizing an HLA-DR4,Dw4-restricted epitope from the 18-kDa antigen of Mycobacterium leprae defined by synthetic peptides.
    Oftung F; Shinnick TM; Mustafa AS; Lundin KE; Godal T; Nerland AH
    J Immunol; 1990 Feb; 144(4):1478-83. PubMed ID: 1689354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis.
    Barnes PF; Mehra V; Hirschfield GR; Fong SJ; Abou-Zeid C; Rook GA; Hunter SW; Brennan PJ; Modlin RL
    J Immunol; 1989 Oct; 143(8):2656-62. PubMed ID: 2507635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell epitopes on the 36K and 65K Mycobacterium leprae antigens defined by human T cell clones.
    Van Schooten WC; Ottenhoff TH; Klatser PR; Thole J; De Vries RR; Kolk AH
    Eur J Immunol; 1988 Jun; 18(6):849-54. PubMed ID: 2454825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.